ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 703109 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 703109; 2) Community: the network communities that were significantly associated with the response to NSC 703109; 3) Molecule: the relationships between components within communities and NSC 703109; 4) MDR: the compounds that were significantly associated with the NSC 703109.

NSC Compound Enrichment Correlation
NSC 606497 Camptothecin Derivative 0.0385613993886001 0.25018276
NSC 609259 Null 0.0385613993886001 0.31330899
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.0385613993886001 -0.24971121
NSC 621727 Null 0.0385613993886001 0.39947114
NSC 622297 Null 0.0385613993886001 0.36490998
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.0385613993886001 -0.26779997
NSC 629229 Null 0.0385613993886001 0.37027444
NSC 635449 Copper, chloro[2-[1-(2-pyridinyl)ethylidene][N,N-dipropyl-hydrazinecarbothioamidato-N,N,S]- 0.0385613993886001 0.57110372
NSC 638409 (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide 0.0385613993886001 -0.019448751
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0385613993886001 0.41034741
Total:95  Current:68    [First] [Prev] [Next] [Last]